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ABSTRACT
Introduction: The variability of symptoms and signs caused by central nervous system (CNS) lesions make multiple sclerosis 
difficult to recognize,Introduction: This study adds the evaluation of the independent etiologic factors that may play a role in the devel-
opment of SNHL in a NICU population. We compared neonatal intensive care unit NICU infants with sensorineural hearing loss SNHL 
to age and gender matched normal hearing NICU controls.
Materials and methods: 284 consecutive NICU infants positive to the presence of risk indicators associated with permanent 
congenital, delayed-onset, or progressive hearing loss underwent to global audiological assessment. The following risk factors were 
researched, making a distinction between prenatal and perinatal risk factors: in the first group, family history of permanent childhood 
hearing impairment, consanguinity, pregnant maternal infection and drugs exposition during pregnancy; in the second group, prema-
ture birth, respiratory distress , hyperbilirubinemia requiring exchange tranfusion, very low birth weight, cranio-facial abnormality, 
perinatal infections, ototoxic drugs administration, acidosis, hyponatremia, head trauma.
Results: The analysis of the auditory deficit for infants according to numbers of risk factors showed mean values of: 78 + 28.08 
dB nHL for infants positive to two risk factors; 75.71 + 30.30 dB nHL in cases positive to three risk factors; 96.66 + 34.46 dB nHL for 
four risk factors and 85 + 35 dB nHL in case of >5 risk factors.
Conclusion: NICU infants have greater chances of developing SNHL, because of the presence of multiple risk factors; in fact, 
as the number of coexisting risk factors increases, the prevalence rate of SNHL also increases (r=0.81).
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Introduction
Infants admitted to the neonatal intensive care 
unit (NICU), who represent the 4-8% of all births, 
have an increased risk of developing congenital 
sensorineural hearing loss (2 to 4 cases per 100 
newborn infants)(1, 2); multiple risk factors have 
been associated with sensorineural hearing loss 
(SNHL). Comparing SNHL incidence with that 
of other congenital pathologies routinely screened 
at birth like phenylketonuria (1:15000 newborns) 
and hypothyroidism (1:4500 newborns), 
permanent hearing loss appears more frequent 
especially among NICU population. Unlike 
children with normal hearing, those with hearing 
loss present more difficulty developing verbal 
skills (learning vocabulary, grammar, word order 
and idiomatic expressions), language, learning 
and speech. Hearing impairment influences also 
cognitive and affective development of infants 
making consequences in their interpersonal 
relationships(3-7).
The 2007 Position Statement from the Joint 
Committee on Infant Hearing (JCIH) confirmed 
that neonates who are in NICU for >5 days, or 
who have risk factors and a shorter stay, undergo 
hearing evaluation with Transient evoked 
otoacoustic emissions (TEOAEs) and (automated) 
auditory brainstem response (ABR) testing, that 
is recommended for screening because of the 
increased occurrence of SNHL and neural (auditory 
neuropathy/dyssynchrony) loss that are known to 
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cause long-term problems on language and speech 
development in this population(8).
Some authors have studied the presence of 
risk factors identified by the Joint Committee on 
Infants Hearing (JCIH) among NICU infants(1, 
2, 9-14) but their studies concerned a relative small 
number of NICU infants, or did not have a control 
group of normal hearing infants. Risk factors that 
are commonly found among NICU infants are 
prolonged mechanical ventilation, asphyxia, low 
birth weight and ototoxic medication.
Because most of these risk factors are related 
to NICU admittance it is unclear which risk factors 
play an independent contributing role to SNHL. 
Only by comparison within the NICU population 
the risk factors specific to SNHL can be assessed. 
The Department of Audiology of Palermo 
University represents the main speech and hearing 
third level centre in Western Sicily; it daily performs 
an audiological assessment to those infants at risk 
born in Western Sicily and transferred from NICUs 
to our specialized area(15-17). Therefore this study 
adds the evaluation of the independent etiologic 
factors that may play a role in the development of 
SNHL in a NICU population(18-22). We compared 
NICU infants with SNHL to age and gender 
matched normal hearing NICU controls.
Materials and methods
284 consecutive NICU infants positive 
to the presence of risk indicators associated 
with permanent congenital, delayed-onset, or 
progressive hearing loss underwent to global 
audiological assessment. After ethical Committee 
approval, the study protocol was fully explained 
to patients or their guardians, and written informed 
consent was obtained from each patient. The 
following risk factors were researched, making 
a distinction between prenatal and perinatal risk 
factors (JCIH): in the first group, family history 
of permanent childhood hearing impairment, 
consanguinity, pregnant maternal infection 
(TORCH) and drugs exposition during pregnancy; 
in the second group, premature birth (gestational 
age ≤36 weeks), respiratory distress (IRDS), 
hyperbilirubinemia requiring exchange tranfusion, 
very low birth weight (<1500 g, VLBW), 
cranio-facial abnormality (CFA) and syndromes 
associated to HI, perinatal infections like sepsis 
and meningitis, ototoxic drugs administration 
(furosemide, dexamethason, vancomycin, 
gentamycin and tobramycin), acidosis, 
hyponatremia, head trauma(8).
An experienced audiologist and 
otorhinolaryngologist examined the condition 
of the external auditory canal and tympanic 
membrane with otoscopy, and nose, throat, head 
and face in search of ear anomalies and syndromic 
features related to hearing impairment(23-29).
The audiological assessment was performed by 
the same qualified bio-medical staff and consisted 
of ABR, TEOAE and tympanometry measurement. 
ABR measurements were recorded in a soundproof 
room; all children were in natural sleep or in 
calm conditions throughout the assessment. Both 
ears were sequentially tested. AMPLAID mk22 
auditory evoked potentials system was used for 
testing the infants. After adequate preparation of 
skin, recording silver electrodes were attached to 
upper forehead (recording electrode), the ipsilateral 
mastoid process (reference electrode) and 
contralateral mastoid process (ground electrode). 
Thus the Fpz-M1-M2 electrode montage was 
used for recording the ABR. The acoustic stimuli 
consisted of unfiltered full square wave pulses of 
100 microseconds duration and with alternating 
polarity. The clicks were delivered monaurally 
by a hand-held TDH-49 headphone, at a rate of 
21/sec. The analysis time was 15 milliseconds. 
The recording bandwidth for click threshold 
determination was 100-2500 Hz. The electrode 
and inter electrode impedance were ensured to 
be below 5 kHz and 2 kHz respectively. Each run 
consisted of summing the responses to 2000 clicks. 
Click stimuli were presented starting at a level of 
90 dB nHL. With step sizes of 10 dB the level 
was decreased until no response was found. The 
response threshold was estimated by the lowest 
level at which a response was found.
An infant was considered to have passed 
the ABR test if a replicable wave V response 
(response present on at least two identical sound 
stimulation levels) was present at 30 dB nHL in 
both the ears while sensorineural hearing loss was 
defined as elevated ABR response thresholds (>40 
dB) in one or both ears. Moreover, the absolute 
latencies and interpeak intervals as well as the 
response thresholds were recorded. Experienced 
clinical specialists interpreted the ABR response 
waves. The response latencies in milliseconds 
were obtained by establishing the peak of the 
wave and reading out the digitally displayed time. 
From the latency intensity curves the level of 
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conductive hearing loss was estimated. TEOAE 
and tympanometry measurement were used to 
confirm the diagnosis of conductive hearing loss 
when available. In particular, the first one was 
performed using the Otodynamics ILO 288 USB 
II system with the standard settings; the stimulus 
level was set to 84 dB SPL, a number of 260 
averages was used. Tympanometry was performed 
through Amplaid 766, with a probe frequency of 
220 Hz and an air pressure range of -400 to -100 
mmH2O with automatic recording.
The parents of an infant with suspicion of 
hearing impairment were informed of the results 
of the initial test and received recommendations 
to return for a follow up evaluation after 3 weeks. 
Statistical analysis was conducted with Matlab® 
computer programme; χ2 test, odds ratio (or) and/
or exact test of Fisher test were used, following 
usual conditions of application. Significance was 
set at 0.05.
Results
Of 284 NICU infants examined 168 were 
males (59.15%) and 116 females (40.85%) with a 
male:female ratio = 1.45; the age of infants at first 
diagnostic ABR measurement, ranged from 4 to 20 
weeks of life, with no statistical difference among 
the sex (t = 0.74; f.d. = 140; p = 0.26). 
Audiologic evaluation revealed the presence 
of hearing loss in 34 children (16 male and 18 
female) corresponding to 11.97% of the study 
group (Table 1).
There is no statistically significant difference 
in prevalence of SNHL among sex (χ2 = 1.17, P 
= 0.25, or = 1.74). Out of 34 SNHL infants, 30 
subjects (88.23%) were diagnosed with bilateral 
SNHL; a symmetric HL, defined by an inter-aural 
threshold difference < 30 dB, was evidenced in the 
93.33% corresponding to 28 cases (82.35% of the 
total infants suffering from SNHL), while in the 
5.88 % corresponding to 2 cases this sensorineural 
hearing loss was asymmetric (inter-aural threshold 
difference > 30 dB). 
Finally, 4 infants (11.76%) were affected by 
unilateral SNHL, with a response threshold in the 
best hearing ear < 40 dB. Among the total ears 
suffering from SNHL, our study evidenced an 
hearing threshold mean value of 82.5 ± 30.37 dB 
HL (median 75 dB HL) for the left ears, of 81.25 
± 33.04 dB HL (median 70dB HL) for the right 
ears, of 81.87± 32.05 dB HL (median 70 dB HL) 
for both ears without any difference between left 
and right ears (t=0.18, f.d.=30, P=0.85). The ABR 
response thresholds were used also to determine 
the degree of SNHL; a moderate, defined as hearing 
threshold inferior to 70 dB nHL, hearing loss was 
identified in 52.94% of SNHL corresponding to 18 
infants, severe hearing loss in 11.76% (4 cases) 
and profound hearing loss in 35.29% of cases (12 
cases).
44 NICU infants (15.49%) resulted positive 
for a specific risk factor while 142 subjects (50%) 
were positive for 2 risk factors, 48 cases (16.90%) 
presented 3 risk factors, 34 (11.97%) infants 
demonstrated 4 risk factors while only in 16 case 
>5 risk factors were found. 
Prevalence of prenatal risk factors was 
lower than that of perinatal risk factors (Table 
1) even if TORCH infection resulted an 
independent risk factor for SNHL (or=2.90).
In the second group, that includes risk 
factors occurred from birth to the 28th day 
of life, respiratory distress and prematurity 
showed the highest prevalence, with 140 
infants suffered from IRDS (49.29%) 
and 88 born preterm (30.98%). Lower 
percentage concerned other risk factors like 
hyperbilirubinemia requiring phototherapy, 
found in 50 newborns (17.60%), VLBW, that 
regarded 56 infants (19.71%), syndromes 
associated with HI and cranio -facial 











Family history of HI 6 4(66.6) 2(33.3) 3.88 0.10 0.68-22.01
TORCH 15 11 (73.3) 4(26.6) 2.90 0.071 0.87-
9.67
Drugs administration in pregnant 18 16 (88.8) 2(11.1) 0.91 0.90 0.20-
4.16
Prematurity 88 72(81.8) 16(18.2) 2.20 0.030 1.06-4.55
IRDS 140 120(85.7) 20(16.6) 1.79 0.11 0.87-
3.68
Hyperbilirubinemia 50 38(76) 12(24) 3.04 0.0039 1.39-
6.66
VLBW 56 48(85.7) 8(14.3) 1.29 0.55 0.55-3.04
Perinatal infections 36 34(94.4) 2(5.5) 0.40 0.20 0.09-1.73
Ototoxic drugs 40 36(90) 4(10) 0.79 0.67 0.26-2.38
CFA and Syndromes associated to HI 22 22(100) 0(0) - - -
*Percentage rate relative to total cohort
Table 1: Analisys of risk factors for SNHL among NICU newborns: 
logistic regression analisys, correlation coefficient b, P-value, odds 
ratio and 95% confidence limits.
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The univariant analysis showed a statistically 
significant correlation between prematurity, 
hyperbilirubinemia and SNHL (P=0.03 with 
or=2.20 and P=0.0039 with or=3.04) with a SNHL 
prevalence respectively of 47.05% and 35.29% for 
infants with this risk factor (Table 1).
The study of the risk factors of the SNHL 
infant population demonstrated the presence of 
more risk factors in the 100%; moreover, as the 
number of coexisting risk factors increased, the 
percentage value of SNHL in infants also increases. 
In fact, among the 142 infants presenting two risk 
factors 16 were diagnosed with SNHL (11.26%), 
of the 48 infants with three risk factors 8 were 
deafness (16.6%); 6 infants (21.42%) among the 
28 with four risk factors resulted deaf and 4 infants 
of the 12 (33.33%) positive to >5 risk factors was 
hearing impaired (r = 0.81).
The analysis of the auditory deficit for infants 
according to numbers of risk factors showed mean 
values of: 78 + 28.08 dB nHL for infants positive 
to two risk factors; 75.71 + 30.30 dB nHL in cases 
positive to three risk factors; 96.66 + 34.46 dB 
nHL for four risk factors and 85 + 35 dB nHL in 
case of >5 risk factors.
Discussion
In the general population, a newborn every 
500-1000 births presents permanent hearing 
impairment (HI) greater than the incidence of 
other diseases routinely screened at birth(30-41). 
Moreover, in certain ‘higher risk’ populations, this 
incidence could increase to 8-100 cases per 1000 
infants. The importance of deafness for the public 
health comes from its tendency to cause sequelae 
and complications such as irreversible delay in 
speech and cognitive development. To prevent 
these complications, children especially who have 
certain risk factors for HI must be identified within 
three months of birth, with formal diagnosis and 
initiation of early intervention beginning before 
the 6th month of age. The goal of this report 
was to present the results of global audiological 
evaluation of 142 NICU infants for permanent 
congenital, delayed-onset, or progressive hearing 
loss, who were transferred to our Department, 
the main tertiary Speech and Hearing Center of 
Western Sicily, from all NICU centres of Western 
Sicily that decided to participate in the study from 
January 2010 to our days. 
With a prevalence rate of 11.97% of SNHL, 
our percentage is higher than those reported by 
Coenraad (1.39%), Hille (3.1%) and Robertson 
(3.2%) and inferior to those evidenced by Davis and 
Parving (32.8%), Shiu et al. (30.9%) and Pitt (32%) 
(2, 9; 41-45). According to Dauman et al., the high 
variability in incidence of SNHL among newborns 
admitted to NICU reflects an heterogeneous 
distribution of different neonatal risk factors more 
or less involved in the development of SNHL(46-53).
In addition, another consideration should be 
made for NICU babies: these newborns, in fact, 
present often multiple risk factors, a condition that 
increases the probability of hearing impairment. 
Table 1 reports logistic regression analysis for 
each risk factors in our NICU cohort; results of 
a simultaneous multiple regression analysis of the 
variation in SNHL prevalence among NICU infants 
evidenced that the relative risk for SNHL increases 
by 21.24% in preterm infants and by 19.33% in 
newborns who suffered from hyperbilirubinemia 
when respiratory distress is concomitant with these 
risk factors respectively (Figure 2). Furthermore, 
in this cohort, we observed an higher risk of SNHL 
(99.66%) in case of coexistence of prematurity and 
hyperbilirubinemia. 
Our study also underlined the role of 
gestational age and birth weight as risk factors for 
SNHL; specifically, among the 72 preterm infants, 
58 (80.55%) presented extreme prematurity and of 
them 14 (corresponding to 24.13% subjects) were 
hearing impaired (χ2=10.23; P=0.001). Among 
newborns with very low birth weight, it was 
evidenced a statistically difference between infants 
with weight < 1000g and those who weighed 
at birth≥1000g; in fact the SNHL prevalence 
Figure 1: Figure 1: Incidence of risk factors in SNHL in-
fants respect to NHL cohort.
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percentages inside the groups resulted of 14.28%, 
5.26% and 33.33% for the total infants with 
VLBW, for newborns weighed between 1000g and 
1500 g and for children with extremely low birth 
weight (<1000g) respectively (χ2=3.93; P=0.04). 
These findings are explainable considering that the 
greater the severity of prematurity and the lower 
the birth weight, more probable is the coexistence 
of condition like severe birth asphyxia or assisted 
ventilation for ≥5 days that increase the risk of 
SNHL(54-65).
Conclusion
With an incidence of 11.97% of SNHL in 
infants at risk this study demonstrates the necessity 
to implement a Newborn Hearing Screening 
program in Western Sicily; with a mean hearing 
threshold of 82.5 ± 30.37 dB HL (median 75 dB 
HL), out of speech spectrum, it underlines the 
necessity of an early diagnosis before the 6th 
month of life to prevent sequelae and complications 
such as irreversible delay in speech and cognitive 
development. NICU infants have greater chances 
of developing SNHL, because of the presence of 
multiple risk factors; in fact, as the number of 
coexisting risk factors increases, the prevalence 
rate of SNHL also increases (r=0.81), particularly 
among extreme premature and infants with weight 
< 1000g (P=0.04).
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